Disclosed is a method for detecting cancer using a protein that is expressed in many types of cancer. Also disclosed is a pharmaceutical composition for treating or preventing cancer, which targets the protein. Further disclosed is a pharmaceutical composition comprising a cancer antigen peptide derived from the protein. Specifically, the method comprises a step of determining the occurrence or quantity of an eEF2 polypeptide or an eEF2 antibody in a sample collected from a subject.
